机构

• 上海药物研究所 [48]

采集方式

• OAI收割 [48]

内容类型

• 期刊论文 [47]
• 会议论文 [1]

发表日期

• 2024 [1]
• 2023 [2]
• 2022 [5]
• 2020 [1]
• 2019 [3]
• 2018 [3]
• 更多

学科主题

• Oncology [3]

筛选

浏览/检索结果: 共48条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 A robust and validated LC-MS/MS method for the quantification of ramucirumab in rat and human serum using direct enzymatic digestion without immunoassay 期刊论文  OAI收割 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2024, 卷号: 1234, 页码: 11 作者:  Huang, Wen-si;  Li, Wei-qiang;  Yu, Xiong;  Xue, Ming-zhen;  Yuan, Ya-li   |  收藏  |  浏览/下载：20/0  |  提交时间：2024/04/09 Anti -gastric cancer monoclonal antibody  Ramucirumab  LC -MS/MS  Method validation  Surrogate peptide   Development, Validation and Application of a Bridging ELISA for Detection of Antibodies against GQ1001 in Cynomolgus Monkey Serum 期刊论文  OAI收割 MOLECULES, 2023, 卷号: 28, 期号: 4, 页码: 1684 作者:  Liu, Tingting;  Sun, Yajun;  Deng, Xiaojie;  Shi, Lili;  Chen, Wenyi   |  收藏  |  浏览/下载：3/0  |  提交时间：2024/03/27 antibody-drug conjugate  immunogenicity  anti-drug antibody  bridging ELISA   Development of a bridging ELISA for detection of antibodies against ZV0203 in cynomolgus monkey serum 期刊论文  OAI收割 JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 卷号: 119, 页码: 10 作者:  Liu, Tingting;  Tong, Yongliang;  Gao, Jinli;  Fang, Wenjing;  Wu, Junliang   |  收藏  |  浏览/下载：21/0  |  提交时间：2023/04/10 Antibody-drug conjugate  Immunogenicity  Anti-drug antibody  Bridging ELISA   Inner nuclear membrane protein TMEM201 maintains endothelial cell migration and angiogenesis by interacting with the LINC complex 期刊论文  OAI收割 JOURNAL OF MOLECULAR CELL BIOLOGY, 2022, 卷号: 14, 期号: 3, 页码: mjac017 作者:  Zhang, Yutian;  Kong, Ya;  Guo, Haoran;  Liu, Yun;  Zang, Yi   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/03/21 transmembrane protein 201  inner nuclear membrane  LINC complex  endothelial cell  migration  angiogenesis   HMGN4 plays a key role in STAT3-mediated oncogenesis of triple-negative breast cancer 期刊论文  OAI收割 CARCINOGENESIS, 2022, 页码: 11 作者:  Mou, Jiahui;  Xu, Xiaoding;  Wang, Feifei;  Kong, Weiwen;  Chen, Jing   |  收藏  |  浏览/下载：18/0  |  提交时间：2022/09/30 Qualitative and quantitative determination of the primary active components and metabolites in human plasma after oral administration of Shuanghuanglian liquid 期刊论文  OAI收割 JOURNAL OF SEPARATION SCIENCE, 2022, 页码: 12 作者:  Zhang, Shengman;  Liu, Ying;  Peng, Ni;  Chen, Xiaoyan   |  收藏  |  浏览/下载：17/0  |  提交时间：2022/08/16 baicalin  chlorogenic acid  forsythin  liquid chromatography-tandem mass spectrometry  Shuanghuanglian liquid   Conserved protein targets for developing pan-coronavirus drugs based on sequence and 3D structure similarity analyses 期刊论文  OAI收割 COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 卷号: 145, 页码: 105455 作者:  Ma, Minfei;  Yang, Yanqing;  Wu, Leyun;  Zhou, Liping;  Shi, Yulong   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/03/21 Pharmaceutical informatics  Drug design  Target discovery  Medicinal chemistry  Broad-spectrum drugs   Simultaneous determination of almonertinib and its active metabolite HAS-719 in human plasma by LC-MS/MS: Evaluation of pharmacokinetic interactions 期刊论文  OAI收割 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2022, 卷号: 1197, 页码: 7 作者:  Liu, Lu;  Yang, Le;  Li, Wei;  Chen, Xiaoyan   |  收藏  |  浏览/下载：20/0  |  提交时间：2022/08/16 Almonertinib  LC -MS  MS  Active metabolite (HAS-719)  Pharmacokinetic drug-drug interaction   Identification and characterization of isocitrate dehydrogenase 1 (IDH1) as a functional target of marine natural product grincamycin B 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 13 作者:  Wang, Zheng;  Li, Zeng-xia;  Zhao, Wen-cao;  Huang, Hong-bo;  Wang, Jia-qi   |  收藏  |  浏览/下载：55/0  |  提交时间：2020/12/24 grincamycin B  marine natural product  isocitrate dehydrogenase 1  apoptosis  ER stress  intracellular ROS  Zebrafish embryos  hematological malignancies   Simultaneous inhibition of PI3K alpha and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer 期刊论文  OAI收割 CANCER BIOLOGY & MEDICINE, 2019, 卷号: 16, 期号: 1, 页码: 66-+ 作者:  Wang, Yuxiang;  Li, Xian;  Liu, Xueling;  Chen, Yi;  Yang, Chunhao   |  收藏  |  浏览/下载：21/0  |  提交时间：2020/07/01 PI3K alpha  CDK4/6  KRAS  NSCLC  CYH33